Publications
Publications
Show Results For
- All HBS Web
(8,631)
- Faculty Publications (1,381)
- 2023
- Working Paper
Interest-Rate Risk and Household Portfolios
By: Sylvain Catherine, Max Miller, James Paron and Natasha Sarin
How are households exposed to interest-rate risk? When rates fall, households face lower future expected returns but those holding long-term assets—disproportionately the wealthy and middle-aged—experience capital gains. We study the hedging demand for long-term assets... View Details
- September 2023
- Technical Note
Note on Family Constitutions
Less than half of family businesses will survive generational transfer. While sometimes this is due to operating company issues, in many cases it is because of conflict within the family. Many families create and adopt a family constitution to proactively mitigate... View Details
- 2023
- Working Paper
Navigating the Jagged Technological Frontier: Field Experimental Evidence of the Effects of AI on Knowledge Worker Productivity and Quality
By: Fabrizio Dell'Acqua, Edward McFowland III, Ethan Mollick, Hila Lifshitz-Assaf, Katherine C. Kellogg, Saran Rajendran, Lisa Krayer, François Candelon and Karim R. Lakhani
The public release of Large Language Models (LLMs) has sparked tremendous interest in how humans will use Artificial Intelligence (AI) to accomplish a variety of tasks. In our study conducted with Boston Consulting Group, a global management consulting firm, we examine... View Details
- September 2023
- Technical Note
Note on Difficult Conversations in the Family Enterprise
The best time to have a difficult conversation is, ideally, as soon as possible. Engaging in challenging conversations early can produce beneficial results for several reasons, such as resolving issues, improving communication, preserving relationships, and increasing... View Details
- September 2023 (Revised April 2024)
- Case
Atomwise: Strategic Opportunities in AI for Pharma
By: Satish Tadikonda
Abraham Heifets and his co-founder, Izhar Wallach, had founded Atomwise to develop i) an AI engine to transform drug discovery by creating better medicines faster, and ii) a machine learning-based discovery engine that combined the power of convolutional neural... View Details
- September–October 2023
- Article
The New Era of Industrial Policy Is Here
By: Willy C. Shih
Governments around the world are increasingly intervening in the private sector through industrial policies designed to help domestic sectors reach goals that markets alone are unlikely to achieve. Companies in targeted sectors—such as automakers, energy companies, and... View Details
- September–October 2023
- Article
What Does 'Stakeholder Capitalism' Mean to You?: A Guide to the Four Main Types
By: Lynn S. Paine
Business leaders are being urged to adopt a multistakeholder approach to governance in place of the shareholder-centered approach that has guided their work for several decades. But through hundreds of interviews with directors, executives, investors, governance... View Details
- August 2023
- Teaching Note
Kunshan, Incorporated: The Making of China’s Richest Town
By: William C. Kirby and Noah B. Truwit
Teaching Note for HBS Case No. 313-103. The case is designed to give the students an understanding of the local Chinese entrepreneurial state and how foreign and Chinese firms have worked with it to create China’s richest small city. The major themes are—local state... View Details
- 2023
- Working Paper
Corporate Leaders Say They Are for Stakeholder Capitalism—But Which Version Exactly?: A Critical Look at Four Varieties
By: Lynn S. Paine
The past few years have seen an outpouring of articles and statements heralding the
arrival of a new and more inclusive form of capitalism often called stakeholder capitalism. The
new capitalism promises to strengthen companies, improve outcomes for their... View Details
- 2023
- Working Paper
Do Third-Party Guarantors Reassure Foot Soldiers?
By: Natalia Garbiras-Díaz, Michael Weintraub, Leopoldo Fergusson, Juana Catalina Garcia Duque and Laia Balcells
Since the end of the Cold War, international third parties such as the United Nations (UN) have become frequent guarantors of peace agreements. Existing studies document that third parties provide assurances that help maintain peace, yet these studies nearly... View Details
- July 2023 (Revised June 2025)
- Case
The Miccosukee Tribe and the Battle to Save the Everglades (A): A Miami Climate Action Story
By: Rosabeth Moss Kanter and Joyce J. Kim
The Miccosukee Indians, a small tribe of indigenous people in South Florida, have a long-standing interest in protecting the land, waterways, and habitats of the Everglades, their ancestral home, which serves as a watershed for urban areas in Miami-Dade County and a... View Details
- July 2023
- Case
Honeycomb
By: Jeffrey J. Bussgang and Kumba Sennaar
Honeycomb, an audio app enabling seniors to record stories and save family memories, suddenly draws interest from a younger user demographic. The co-founders consider pivoting to better serve this new user demographic. How should they think about strategy, brand, and... View Details
- 18 Jul 2023
- Interview
Jeffrey Rayport on Product Market Fit, Profit Market Fit and Whiplash, and More
By: Jeffrey F. Rayport and Doug Levin
This episode of "Lessons from Startup Life" podcast features Jeffrey Rayport, Senior Lecturer of Business Administration at the Harvard Business School. Jeffrey specializes in teaching and researching growth-stage technology ventures and their scalability. Prior to... View Details
- 2023
- Working Paper
The Market for Sharing Interest Rate Risk: Quantities and Asset Prices
By: Ishita Sen, Umang Khetan, Jane Li and Ioana Neamtu
We study the extent of interest rate risk sharing across the financial system using granular positions and transactions data in interest rate swaps. We show that pension and insurance (PF&I) sector emerges as a natural counterparty to banks and corporations: overall,... View Details
- June 2023
- Teaching Note
Agricultural Revolution without a Land Revolution: The Megafarms of CP Group
By: William C. Kirby and Noah B. Truwit
Teaching Note for HBS Case No. 316-150. The case introduces students to an innovative new agricultural venture on the outskirts of Beijing. It can be used as a platform to discuss broader issues of agricultural policy reform and regional disparities in social and... View Details
- June 2023
- Case
Tractor Supply Co
By: David L. Ager and Michael A. Roberto
In February 2023, Hal Lawton, CEO of Tractor Supply Co, the largest farm and ranch retailer in the United States reflected on the company’s 70% growth between 2019 and 2022. Economists had begun to predict an economic downturn and experts were predicting softening... View Details
- June 2023
- Article
Gaining Organizational Adoption: Strategically Pacing the Deployment of Digital Innovations
By: Rebecca Karp
Scholars have long suggested that to foster adoption for their innovative products and services, entrepreneurs should engage with customers to better understand their unmet needs. Yet, customers frequently reside in organizations, and organizational members may not be... View Details
- June 2023
- Article
Regulatory Limits to Risk Management
By: Ishita Sen
Variable annuities, the largest liability of U.S. life insurers, are investment products containing long-dated minimum return guarantees. I show that guarantees with similar economic risks are treated differently by regulation and these differences impact insurers’... View Details
- 2023
- Working Paper
Sovereign Default and the Decline in Interest Rates
By: Max Miller, James Paron and Jessica Wachter
Sovereign debt yields have declined dramatically over the last half-century. Standard explanations, including aging populations and increases in asset demand from abroad, encounter difficulties when confronted with the full range of evidence. We propose an explanation... View Details
- June 2023
- Case
Verve Therapeutics: Taking DNA Editing to Heart
By: Shikhar Ghosh and Shweta Bagai
Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing... View Details